US Patent Issued to RIN INSTITUTE, NATIONAL CANCER CENTER on April 14 for "Fibrin-binding antibody and pharmaceutical composition containing antibody" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,797, issued on April 14, was assigned to RIN INSTITUTE INC. (Tokyo) and NATIONAL CANCER CENTER (Tokyo).

"Fibrin-binding antibody and pharmaceutical composition containing antibody" was invented by Yasuhiro Matsumura (Chiba, Japan), Shingo Hanaoka (Chiba, Japan) and Shinji Saijo (Chiba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an antibody that binds to fibrin and a pharmaceutical composition containing the antibody. According to the present invention, there is particularly provided a humanized antibody that binds to fibrin and a pharmaceutical composition containing the antibody."

The patent was filed on M...